Jefferies Lifts PT on salesforce.com (CRM) to $125; New Patent Infringement Notice
Tweet Send to a Friend
Jefferies boosted its price target on Buy-rated salesforce.com (NYSE: CRM) from $200 to $125 saying it remains the best growth ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
